Cargando…
Nicotinamide polymeric nanoemulsified systems: a quality-by-design case study for a sustained antimicrobial activity
Nicotinamide, the amide form of vitamin B3, was demonstrated to combat some of the antibiotic-resistant infections that are increasingly common around the world. The objective of this study was to thoroughly understand the formulation and process variabilities affecting the preparation of nicotinami...
Autores principales: | , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4835127/ https://www.ncbi.nlm.nih.gov/pubmed/27110111 http://dx.doi.org/10.2147/IJN.S102945 |
_version_ | 1782427573675884544 |
---|---|
author | Zidan, Ahmed S Ahmed, Osama AA Aljaeid, Bader M |
author_facet | Zidan, Ahmed S Ahmed, Osama AA Aljaeid, Bader M |
author_sort | Zidan, Ahmed S |
collection | PubMed |
description | Nicotinamide, the amide form of vitamin B3, was demonstrated to combat some of the antibiotic-resistant infections that are increasingly common around the world. The objective of this study was to thoroughly understand the formulation and process variabilities affecting the preparation of nicotinamide-loaded polymeric nanoemulsified particles. The quality target product profile and critical quality attributes of the proposed product were presented. Plackett–Burman screening design was employed to screen eight variables for their influences on the formulation’s critical characteristics. The formulations were prepared by an oil-in-water emulsification followed by solvent replacement. The prepared systems were characterized by entrapment capacity (EC), entrapment efficiency (EE), particle size, polydispersity index, zeta potential, transmission electron microscopy, Fourier transform infrared spectroscopy, differential scanning calorimetry, powder X-ray diffraction, in vitro drug release, and their antibacterial activity against bacterial scrums. EC, EE, particle size, polydispersity index, zeta potential, and percentage release in 24 hours were found to be in the range of 33.5%–68.8%, 53.1%–67.1%, 43.3–243.3 nm, 0.08–0.28, 9.5–53.3 mV, and 5.8%–22.4%, respectively. One-way analysis of variance and Pareto charts revealed that the experimental loadings of 2-hydroxypropyl-β-cyclodextrin and Eudragit(®) S100 were the most significant for their effects on nicotinamide EC and EE. Moreover, the polymeric nanoemulsified particles demonstrated a sustained release profile for nicotinamide. The Fourier transform infrared spectroscopy, differential scanning calorimetry, and X-ray diffraction demonstrated a significant interaction between the drug and 2-hydroxypropyl-β-cyclodextrin that might modulate the sustained release behavior. Furthermore, the formulations provided a sustained antibacterial activity that depended on nicotinamide-loading concentration, release rate, and incubation time. In conclusion, the study demonstrated the potential of polymeric nanoemulsified system to sustain the release and antibacterial activity of nicotinamide. |
format | Online Article Text |
id | pubmed-4835127 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2016 |
publisher | Dove Medical Press |
record_format | MEDLINE/PubMed |
spelling | pubmed-48351272016-04-22 Nicotinamide polymeric nanoemulsified systems: a quality-by-design case study for a sustained antimicrobial activity Zidan, Ahmed S Ahmed, Osama AA Aljaeid, Bader M Int J Nanomedicine Original Research Nicotinamide, the amide form of vitamin B3, was demonstrated to combat some of the antibiotic-resistant infections that are increasingly common around the world. The objective of this study was to thoroughly understand the formulation and process variabilities affecting the preparation of nicotinamide-loaded polymeric nanoemulsified particles. The quality target product profile and critical quality attributes of the proposed product were presented. Plackett–Burman screening design was employed to screen eight variables for their influences on the formulation’s critical characteristics. The formulations were prepared by an oil-in-water emulsification followed by solvent replacement. The prepared systems were characterized by entrapment capacity (EC), entrapment efficiency (EE), particle size, polydispersity index, zeta potential, transmission electron microscopy, Fourier transform infrared spectroscopy, differential scanning calorimetry, powder X-ray diffraction, in vitro drug release, and their antibacterial activity against bacterial scrums. EC, EE, particle size, polydispersity index, zeta potential, and percentage release in 24 hours were found to be in the range of 33.5%–68.8%, 53.1%–67.1%, 43.3–243.3 nm, 0.08–0.28, 9.5–53.3 mV, and 5.8%–22.4%, respectively. One-way analysis of variance and Pareto charts revealed that the experimental loadings of 2-hydroxypropyl-β-cyclodextrin and Eudragit(®) S100 were the most significant for their effects on nicotinamide EC and EE. Moreover, the polymeric nanoemulsified particles demonstrated a sustained release profile for nicotinamide. The Fourier transform infrared spectroscopy, differential scanning calorimetry, and X-ray diffraction demonstrated a significant interaction between the drug and 2-hydroxypropyl-β-cyclodextrin that might modulate the sustained release behavior. Furthermore, the formulations provided a sustained antibacterial activity that depended on nicotinamide-loading concentration, release rate, and incubation time. In conclusion, the study demonstrated the potential of polymeric nanoemulsified system to sustain the release and antibacterial activity of nicotinamide. Dove Medical Press 2016-04-12 /pmc/articles/PMC4835127/ /pubmed/27110111 http://dx.doi.org/10.2147/IJN.S102945 Text en © 2016 Zidan et al. This work is published and licensed by Dove Medical Press Limited The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. |
spellingShingle | Original Research Zidan, Ahmed S Ahmed, Osama AA Aljaeid, Bader M Nicotinamide polymeric nanoemulsified systems: a quality-by-design case study for a sustained antimicrobial activity |
title | Nicotinamide polymeric nanoemulsified systems: a quality-by-design case study for a sustained antimicrobial activity |
title_full | Nicotinamide polymeric nanoemulsified systems: a quality-by-design case study for a sustained antimicrobial activity |
title_fullStr | Nicotinamide polymeric nanoemulsified systems: a quality-by-design case study for a sustained antimicrobial activity |
title_full_unstemmed | Nicotinamide polymeric nanoemulsified systems: a quality-by-design case study for a sustained antimicrobial activity |
title_short | Nicotinamide polymeric nanoemulsified systems: a quality-by-design case study for a sustained antimicrobial activity |
title_sort | nicotinamide polymeric nanoemulsified systems: a quality-by-design case study for a sustained antimicrobial activity |
topic | Original Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4835127/ https://www.ncbi.nlm.nih.gov/pubmed/27110111 http://dx.doi.org/10.2147/IJN.S102945 |
work_keys_str_mv | AT zidanahmeds nicotinamidepolymericnanoemulsifiedsystemsaqualitybydesigncasestudyforasustainedantimicrobialactivity AT ahmedosamaaa nicotinamidepolymericnanoemulsifiedsystemsaqualitybydesigncasestudyforasustainedantimicrobialactivity AT aljaeidbaderm nicotinamidepolymericnanoemulsifiedsystemsaqualitybydesigncasestudyforasustainedantimicrobialactivity |